Target N. V. Biotech, 10% Owner at MACROGENICS INC (MGNX), bought 200,000 shares at $18.50 ($3.7M) on 2021-11-19, disclosed to the SEC on 2021-11-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| MGNX | BUY | 2023-01-23 | $795K | — | Filing → |
| MGNX | BUY | 2022-11-25 | $1.8M | — | Filing → |
| MTEM | BUY | 2022-05-18 | $236K | — | Filing → |